Pith Wave Signal

1 stories tagged #dystrophic epidermolysis bullosa

Newest Most read
  1. LEO Pharma Acquires Replay's Gene Therapy Platform for $50 Million
    health

    LEO Pharma Acquires Replay's Gene Therapy Platform for $50 Million

    LEO Pharma acquires Replay's HSV gene therapy platform for $50M upfront, targeting rare dermatological conditions like dystrophic epidermolysis bullosa.

    last mo. 1 min read